SCHEMBL27409249

SCHEMBL27409249

OB(O)c1ccc(CNc2ncnc3cn[nH]c23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.44
PRMT1 Q99873 1/20 0.40
EGFR P00533 10/20 0.39
NR2F2 P24468 3/20 0.39
GALR3 O60755 2/20 0.39
RAB9A P51151 1/20 0.39
TSHR P16473 2/20 0.39
MAPK1 P28482 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 1/20 0.39
CDK2 P24941 1/20 0.39
USP10 Q14694 1/20 0.39
PIK3C3 Q8NEB9 1/20 0.39
USP13 Q92995 1/20 0.39
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CXCR1 P25024 2/20 0.38
CXCR2 P25025 2/20 0.38
CCNB2 O95067 1/20 0.37
CDK1 P06493 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27409710 0.81 PRMT1 (0.43) LMNAPRMT1EGFRNR2F2GALR3
SCHEMBL27244274 0.80 ENPP1 (0.55) LMNAPRMT1EGFRNR2F2GALR3
SCHEMBL27409993 0.80 HDAC6 (0.40) CXCR1CXCR2
SCHEMBL27409392 0.77 CCNB2 (0.34) CDK2CXCR1CXCR2CCNB2CDK1
SCHEMBL27409396 0.76 PDE5A (0.49) LMNATSHRMAPK1CYP1A2CYP2D6
SCHEMBL27409246 0.75 PRMT1 (0.70) LMNAPRMT1RAB9ATSHRMAPK1
SCHEMBL22164646 0.75 EGFR (0.71) LMNAEGFRNR2F2GALR3RAB9A
SCHEMBL27410555 0.73 PRMT1 (0.41) LMNAPRMT1EGFRTSHRMAPK1
SCHEMBL30097237 0.73 PRMT1 (0.41) LMNAPRMT1EGFRTSHRMAPK1
Formic Acid SCHEMBL30097166 0.73 CXCR1 (0.32) CXCR1CXCR2CCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC 2024-06-27 US disclosed
WO-2022197734-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS RIBOSCIENCE LLC (US) 2022-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209005-A1 BICYCLIC HETEROARYL BORONATE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS ENPP1, ENPP3, ENTPD5 LMNA 2452/4885PRMT1 1246/4885EGFR 4139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.